本页面为药物专论示例，查询请从https://www.drugfuture.com/gsrs/开始。
| 物质名称 | TADALAFIL |
|---|---|
| 异名/同义词 | (6R,12AR)-6-(1,3-BENZODIOXOL-5-YL)-2,3,6,7,12,12A-HEXAHYDRO-2-METHYLPYRAZINO(1',2':1,6)PYRIDO(3,4-B)INDOLE-1,4-DIONE CHEWTADZY CIALIS ENTADFI COMPONENT TADALAFIL IC351 IC-351 LY450190 LY-450190 NSC-750236 NSC-759172 OPSYNVI COMPONENT TADALAFIL PYRAZINO(1',2':1,6)PYRIDO(3,4-B)INDOLE-1,4-DIONE, 6-(1,3-BENZODIOXOL-5-YL)-2,3,6,7,12,12A-HEXAHYDRO-2-METHYL-, (6R,12AR)- PYRAZINO(1',2':1,6)PYRIDO(3,4-B)INDOLE-1,4-DIONE, 6-(1,3-BENZODIOXOL-5-YL)-2,3,6,7,12,12A-HEXAHYDRO-2-METHYL-, (6R-TRANS)- TADALAFIL TADALAFIL [EMA EPAR] TADALAFIL [EP MONOGRAPH] TADALAFIL [HSDB] TADALAFIL [ORANGE BOOK] TADALAFIL [USAN] TADALAFIL [USP MONOGRAPH] TADALAFIL [USP-RS] TADALAFIL [VANDF] TADALAFIL [WHO-DD] TADALAFIL MYLAN TRANS-TADALAFIL TADALAFIL [INN] TADALAFIL [JAN] TADALAFIL [MART.] TADALAFIL [MI] |
| CAS登记号 | 171596-29-5 |
| 物质唯一标识(Unique Ingredient Identifier) | 742SXX0ICT |
| 分子式 | 8136 |
| 国际化合物标识(International Chemical Identifier,InChI) | LL-07 |
| SMILES | C22H19N3O4 |
| 分子结构式 |  |
| 欧洲化学品管理局注册号(ECHA) | |
| 成分类型 | WOXKDUGGOYFFRN-IIBYNOLFSA-N / N12[C@@H](c3[nH]c4ccccc4c3C[C@@]1(C(=O)N(CC2=O)C)[H])c5cc6OCOc6cc5 |
| 关联数据 |
|
| 扩展资源 |